Trial Profile
Evaluating the Feasibility of Using Transdermal Patient-controlled Fentanyl After Spinal Fusions
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2022
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms IONSYS Pilot
- 14 Feb 2018 Status changed from not yet recruiting to withdrawn prior to enrolment due to Contract not reached with sponsor.
- 14 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 14 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.